Final programme

11:30 - O01 Hemoconcentration is major risk factor for central nervous system involvement in hemolytic uremic syndrome - G Ardissino, A Mastrangelo, S Testa, M Belingheri, F Paglialonga, A Edefonti, A Van Lierde, P Castorina, N Borsa, S Tedeschi, F Lalatta (Milano - Italy)
11:40 - O02 The first reported outbreak of HUS caused by E. Coli O103:H25 - L Krogvold, A Bjerre, H Gudmundsdottir, D Brackman, H Dollner, G Syversen, HJ Bangstad (Oslo, Bergen, Trondheim - Norway)
11:50 - O03 Report of the French Registry for children on dialysis - P Niaudet, E Ducamp, P Chaignot, L Le Mignot, JB Richard, P Landais (Paris - France)
12:00 - O04 Double filtration plasmapharesis as an alternative to plasma exchange in paediatrics - F Hussain, M Christian, B Harvey, R Connell (Nottingham - United Kingdom)
12:10 - O05 Cyclosporine A (CyA) versus MP pulses (MP) in severe Henoch-Schönlein nephritis (HSN): outcome after 2 years follow-up - O Jauhola, J Ronkainen, M Ala-Houhala, H Autio-Harmainen, T Holtta, T Jahnukainen, O Koskimies, T Ormala, M Nuutinen (Oulu, Tampere, Helsinki, Turku, Kuopio - Finland)
12:20 - O06 The characteristic of parameters of intrarenal haemodynamics determined by color Doppler ultrasound in children with reflux nephropathy - I Zorin, A Vyalkova, A Miroshnichenko, L Vanyushina, A Karpov, M Vostricova, A Zorin (Orenburg - Russian Fedration)
12:30 - O07 Rituximab treatment for severe steroid dependent nephrotic syndrome: follow up at 6 months of 21 cases - AL Sellier-Leclerc (Paris - France)

11:30 - O08 The natural history of vascular calcification in chronic kidney disease – a bone to pick? - R Shroff, R Mcnair, N Figg, J Skepper, L Schurgers, A Gupta, M Hiorns, J Deanfield, L Rees, C Shanahan (London - United Kingdom, Cambridge - United Kingdom, Maastricht - The Netherlands)
11:40 - O09 Growth hormone treatment in infants under 1 year of age with chronic renal failure (CRF) and end stage renal failure (ESRF) - F Mencarelli, D Kiepe, G Stringini, M Cappa, F Emma (Bologna - Italy, Rome - Italy)
11:50 - O10 Potassium depletion retards growth, alters dynamics and structure of growth plate and causes resistance to the stimulating effect of growth hormone (GH) on longitudinal growth - H Gil-Peña, F Santos, E Carbajo Perez, E Garcia-Lopez, V Loredo, O Alvarez-Garcia, J Rodriguez-Suarez, FA Ordoñez, E Carbajo-Perez (Oviedo - Spain)
12:00 - O11 Are the pediatric K/DOQI bone guidelines appropriate for children on chronic peritoneal dialysis? - F Schaefer, D Borzych, S Testa, M Cantwell, M Lipka, F Ozaltin, AR Watson, G Klaus, E Verrina, S Bakkaloglu, N Aksu, BA Warady (Heidelberg - Germany, Gdansk - Poland, Milano - Italy, London - United Kingdom, Warsaw - Poland, Ankara - Turkey, Nottingham - United Kingdom, Marburg - Germany, Genova - Italy, Izmir - Turkey, Kansas City - United States)
12:10 - O12 Vitamin-D-induced calcification in uremic rats: Effect of cinacalcet (CINA) and parathyroidectomy (PTX) - S Jung, S Krämer, D Müller, H Peters, U Querfeld (Berlin - Germany)
12:20 - O13 Bicarbonate therapy improves Growth in Children with Incomplete Distal Renal Tubular Acidosis - A Sharma, J Grimmer, R Sharma, G Filler (London - Canada, Lucknow - INDIA)
12:30 - O14 Improved Preservation of Ultrafiltration Capacity in Children on Bicarbonate Based PD Solution. Results from a Randomized Controlled Trial (Biokid) - CP Schmitt, G Gemulla, KE Bonzel, T Höltta, S Testa, M Fischbach, J Misselwitz, J Kemper, K Arbeiter, F Schaefer (Heidelberg - Germany, Essen - Germany, Helsinki - Finland, Milano - Italy, Strasbourg - France, Jena - Germany, Hamburg - Germany, Vienna - Austria)

11:30 - O15 The mTOR-pathway is activated in autosomal recessive polycystic kidney disease (ARPKD) -DC Fischer, U Jacoby, L Pape, E Kuwertz-Broecking, H Nizze, U Querfeld, M Kemper, D Haffner (Rostock, Hannover, Muenster Berlin, Hamburg - Germany)
11:40 - O16 Primary Hyperoxaluria type 1: mutation analysis and outcome - S Fargue, J Harambat, A Liutkus, B Ranchin, AM Schott, MO Rolland, P Cochat (Lyon, Bordeaux - France)
11:50 - O17 Clinical and genetic study of primary hyperoxaluria in italy - A Robbiano, G Mandrile, D Giachino, M Petrarulo, D Pirulli, C Zadro, M Marangella, A Amoroso, L Peruzzi, L Murer, S Picca, M de Marchi (Orbassano (To), Torino, Trieste, Padova, Roma - Italy)
12:00 - O18 Sedoheptulokinase deficiency due to a 57-kb deletion in cystinosis patients causes accumulation of sedoheptulose: Elucidation of the function of the CARKL gene - M Wamelink, E Struys, E Jansen, F Zijlstra, U Engelke, H Blom, C Jacob, R Wevers, E Levtchenko (Amsterdam - The Netherlands, Nijmegen - The Netherlands, Leuven - Belgium)
12:10 - O19 Over-expression with re-distribution of laminin-γ3 and colocalization with polycystin 1 in Congenital Polycystic Kidney Mice - YY Chiou, HK Lin, ST Jiang, MJ Tang (Tainan - Taiwan, Province of China, Taipei - Taiwan, Province of China)
12:20 - O20 Renal Functions Of Twenty Seven Children With Methylmalonic Acidemia (MMA): Is There a Good Marker? - HI Aydin, A Duzova, A Dursun, S Sivri, T Aksoy, P Kiratli, A Tokatli, A Bakkaloglu, T Coskun (Ankara - Turkey)
12:30 - O21 - Clinical and genetic studies in 17 families with Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis - R Vargas-Poussou, A Blanchard, G Guest, P Cochat, A May, M Godin, B Horen, T Vendrell, P Houillier, X Jeunemaître (Paris - France, Lyon - France, Evry - France, Rouen - France, Tarbes - France, Barcelone - Spain)

11:30 - O22 Modulation of Toll-Like Receptors expression in human mesangial cells in culture is mediated by aberrantly glycosylated polymeric IgA - R Coppo, E Loiacono, V Minieri, V Daprà, E Ricotti, A Alfarano, R Camilla, L Peruzzi, A Amore (Torino - Italy)
11:40 - O23 TGF-β1 in non-lethal doses causes enhanced migration of cultured podocytes - A Fichtner, M Grossmüller, B Tönshoff, J Oh (Heidelberg - Germany, Heidelberg, Düsseldorf - Germany)
11:50 - O24 Slow nocturnal hemodialysis as an alternative treatment option to improve quality of life in children - A Raes, J Dehoorne, A Deguchtenaere, J Vande Walle (Gent - Belgium)
12:00 - O25 Relationship of Left Ventricular Mass Index (LVMI), Shortening Fraction (SF), Blood Volume Changes (dBV) and Dialysis Associated Morbidity (DAM) with Increased Morbidity Index (MI) and Mortality in HIV Pediatric Subjects on Maintanace Hemodialysis (HD) - R Gordillo, J Kumar, M Del Rio, K Supe-Markovina, R Woroniecki (Bronx - United States)
12:10 - O26 Mid-aortic syndrome: long term outcome of 32 children - A Tummolo, S Marks, M Stadermann, DJ Roebuck, CA Mclaren, G Hamilton, MJ Dillon, K Tullus (Bari - Italy, London - United Kingdom)
12:20 - O27 Some genetic polymorphisms in paediatric essential hypertension - N Marcun Varda, S Stangler Herodez, B Zagradisnik, K Zerjavic, N Kokalj Vokac, A Gregoric (Maribor - Slovenia)
12:30 - O28 Gitelman's syndrome: genotype-phenotype correlation - N Godefroid, E Riveira-Munoz, Q Chang, J Hoenderop, R Bindels, K Dahan, O Devuyst (Brussels - Belgium, Nijmegen - The Netherlands)

11:30 - O29 Follow-up of Cytomegalo- und Adenovirus-specific T cells during the first year after pediatric kidney transplantation - T Ahlenstiel, U Sester, M Sester, A Heim, J Ehrich, L Pape (Hannover - Germany, Homburg - Germany)
11:40 - O30 Quantification of NFAT-regulated gene expression in pediatric renal transplant recipients: A novel approach for pharmacodynamic monitoring of calcineurin inhibitors - H Billing, T Giese, S Rieger, R Feneberg, S Meuer, B Toenshoff (Heidelberg - Germany)
11:50 - O31 Protocol biopsies in pediatric renal allograft recipients : consequences on immunosuppressive management - R Vitkevic, B Aoun, M Colombat, P Callard, O Dunand, A Bensman, T Ulinski (Paris - France)
12:00 - O32 Long-term outcome of renal transplantation in children: a 20-year single centre experience - J Harambat, G Mestrallet, B Ranchin, A Liutkus, V Pichault, L Badet, I Canterino, R Bouvier, X Martin, D Floret, P Cochat (Lyon - France)
12:10 - O33
Factor H related protein 1 (FHR-1) and abnormalities of the complement system in atypical Hemolytic uremic syncrome (aHUS) - B Petzlberger, J Scheiring, S Fründ, S Martini (Innsbruck - Austria, Münster - Germany, Muenchen - Germany)
12:20 - O34 EBVviral load monitoring and reduction of immunosuppression do not successfully prevent PTLDafter pediatric kidney transplantation - F Ginevri, E Di Marco, A Parodi, A Gurrado, C Cirillo, G Botti, I Fontana, U Valente, F Locatelli, P Comoli (Genova - Italy, Pavia - Italy)
12:30 - O35 Does Kidney Graft Grow After Transplantation in Children ? - LS Feltran, P Koch Nogueira, S Ajzen, FA Da Silva, A Pacheco-Silva (São Paulo - Brazil, Sao Paulo - Brazil)

11:30 - O36 Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome - G Zalewski, A Wasilewska, W Zoch-Zwierz, L Chyczewski (Bialystok - Poland, Bia?Ystok - Poland)
11:40 - O37 TRPC6 gene mutations in children with sporadic and familial steroid resistant nephritic syndrome (SRNS) originating from Turkey - S Mir, A Berdeli, O Yavascan (Izmir - Turkey)
11:50 - O38 Actin Stabilization in Podocytes by the Calcimimetic R-568 - J Oh, J Beckmann, N Ehret, M Grossmueller, B Fritsching, R Penzel, P Mundel, F Schaefer, CP Schmitt (Duesseldorf - Germany, Heidelberg - Germany, New York - United States)
12:00 - O39 Bigenic heterozygousity and the development of steroid-resistant focal segmental glomerulosclerosis - M Löwik, E Levtchenko, D Westra, P Groenen, E Steenbergen, J Weening, M Lilien, L Monnens, L Van Den Heuvel (Nijmegen - The Netherlands, Leuven - Belgium, Utrecht - The Netherlands)
12:10 - O40 Long term effect of Rituximab treatment in severe steroid dependent nephrotic syndrome - K Brochard, V Guigonis, AL Leclrec-Sellier, M Dehennault, P Ronco, E Berard, H Nivet, P Niaudet, N Raynaud Mounet, S Taque, B Llanas, F Bouissou (Toulouse, Limoges, Paris, Lille, Nice, Tours, Saint Denis la Réunion, Rennes, Bordeaux - France)
12:20 - O41 Hemopexin causes nephrin-dependent reorganisation of the actin cytoskeleton in podocytes - R Lennon, A Singh, G Welsh, R Coward, L Ni, P Mathieson, W Bakker, M Saleem (Bristol - United Kingdom, Groningen - The Netherlands)
12:30 - O42 Urinary and not plasma monocyte chemoattractant protein-1 correlates with disease activity in paediatric systemic lupus erythematosus - S Marks, V Shah, N Hasson, C Pilkington, K Tullus (London - United Kingdom)

11:30 - O43 Is specific drug toxicity of standard immunosuppressives determined genetically ? : analysis of 200 patients ( pediatric cohort) - R Grenda, S Prokurat, A Ciechanowicz (Warsaw - Poland, Szczecin - Poland)
11:40 - O44 Detection of DNA viral sequences in donor kidney samples: graft biopsy, preservation and washing solutions - L Murer, M Della Vella, G Ghirardo, M Pacenti, GF Zanon, G Palù, L Barzon (Padova - Italy)
11:50 - O45 CYP3A5 and MDR1-3435 polymorphisms during the first year after Transplantation: pharmacokinetics and clinical parameters - M Belingheri, S Tirelli, S Turolo, M Ferraresso, V Martina, P Grillo, L Berardinelli, A Edefonti, L Ghio (Milano - Italy)
12:00 - O46 Pulse wave velocity in healthy children, in patients on dialysis and following kidney transplantation - G Reusz, E Kis, O Cseprekal, A Remport, P Sallay, T Tulassay, A Szabo (Budapest - Hungary)
12:10 - O47 The protective role of erythropoietin (EPO) in renal ischemic reperfusion (I/R) injury: gender differences - A Prokai, A Fekete, K Rusai, V Muller, L Wagner, P Degrell, F Banki, A Vannay, B Szebeni, T Tulassay, JA Szabo (Budapest, Pécs - Hungary)
12:20 - O48 Basiliximab as induction after pediatric renal transplantation with a triple-immunosuppression of MMF, CsA and Prednisone: 2-year-posttransplantation results - A Grossmann (Innsbruck - Austria)
12:30 - O49 Pediatric renal transplantation: report from a French pediatric database - E Allain-Launay, G Roussey-Kesler, G Guest, B Ranchin, A Maisin, JL André, S Cloarec, Y Foucher, C Guyot (Nantes, Paris, Lyon, Nancy, Tours - France)

11:30 - O50 Slit2 impairs monocyte chemotaxis - M Mallik, M Rui-Crow, M Rui- Crow, H Yan, D Chaukos, R Griffiths, TM Coffman, LA Robinson (Toronto - Canada, Durham - United States)
11:40 - O51 Whole AGXT gene sequencing identifies 13 new mutations in a cohort of 35 patients with primary hyperoxaluria type 1 - B Beck, M Wolf, M Feldkötter, A Baasner, M Kemper, U John, B Hoppe (Cologne, Hamburg, Jena - Germany)
11:50 - O52 Effectiveness of antibiotic prophylaxis for children at risk of developing urinary tract infection and renal scarring: Results of a systematic review carried out on behalf of the National Institute for Health and Clinical Excellence (NICE) UK - K Verrier Jones, L Jadresic, M Lakhanpaul, R Mori, K Tullus (London - United Kingdom)
12:00 - O53 Antimicrobial Resistance and Risk Factors of Urinary Tract Infection Caused by Extended-Spectrum Beta-Lactamase-Producing Bacteria in Children - R Topaloglu, I Er, D Gur, B Dogan, Y Bilginer, A Duzova, S Ozen, N Besbas, A Bakkaloglu (Ankara - Turkey)
12:10 - O54 A new imaging strategy for children following UTI: results of an evidence based approach to guideline development carried out for the National Institute for Health and Clinical Excellence (NICE) UK - K Tullus, L Jadresic, M Lakhanpaul, R Mori, K Verrier Jones (London - United Kingdom)
12:20 - O55 Diagnosis of UTI: results of an evidence based approach to guideline development carried out for the National Institute for Health and Clinical Excellence (NICE) UK - L Jadresic, M Lakhanpaul, R Mori, K Tullus, K Verrier Jones (London - United Kingdom)
12:30 - O56 Procalcitonin to predict vesico-ureteral reflux in children with DMSA scintigraphy confirmed acute pyelonephritis: a multicenter European Study - S Leroy, A Galetto-Lacour, C Romanello, A Fernandez-Lopez, D Tuerlinckx, V Smolkin, D Gendrel, G Breart, M Chalumeau (Paris - France, Geneva - Switzerland, No Result - Italy, Barcelona - Spain, Yvoir - Belgium, Afula - Israel)